Quality by Design (QbD)-Based Development and Optimization of a Simple, Robust RP-HPLC Method for the Estimation of Methotrexate

References

• Budzynska, R.; Zakliczynska, H. Postepy Hig. Med. Dosw. (Online). 2004, 58, 108–117.
   PubMedGoogle Scholar
• Longo-Sorbello, G. S.; Bertino, J. R. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 2001, 86, 121–127.
   PubMed Web of Science ®Google Scholar
• McGuire, J. J. Anticancer antifolates: current status and future directions. Curr. Pharm. Des. 2003, 9, 2593–2613.
   PubMed Web of Science ®Google Scholar
• USP-NF. Methotrexate. US Pharmacopeial Convention, USA, 2006, p.1383.
   Google Scholar
• Bluett, J.; Riba-Garcia, I.; Hollywood, K.; Verstappen, S. M.; Barton, A.; Unwin, R. D. A HPLC-SRM-MS based method for the detection and quantification of methotrexate in urine at doses used in clinical practice for patients with rheumatological disease: a potential measure of adherence. Analyst 2015, 11, 1981–1987.
   Web of Science ®Google Scholar
• Wu, D.; Wang, Y.; Sun, Y.; Ouyang, N.; Qian, J. A simple, rapid and reliable liquid chromatography-mass spectrometry method for determination of methotrexate in human plasma and its application to therapeutic drug monitoring. Biomed. Chromatogr. 2015, 13, 1–6.
   Google Scholar
• Begas, E.; Papandreou, C.; Tsakalof, A.; Daliani, D.; Papatsibas, G.; Asprodini, E. Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients. J. Chromatogr. Sci. 2014, 52, 590–595.
   PubMed Web of Science ®Google Scholar
• Summers, M.; Fountaion, K. A Quality by Design (QbD) based method development for the determination of impurities in a peroxide degraded sample of Ziprasidone. Application note no. 720004072EN, page no. 1–6, Waters Corporations, USA.
   Google Scholar
• Alden, P. G.; Potts, W.; Yurach, D. A. A QbD with Design-of-Experiments approach to the development of a chromatographic method for the separation of impurities in Vancomycin. In Application note no 70003719EN, Waters Corporations, USA.
   Google Scholar
• Nishtor, I.; Lebrun, P.; Ceccato, A.; Lecomte, F.; Slama, I.; Oprean, R.; Badarau, E.; Dufour, F.; Dossou, K. S.; Fillet, M.; Liegeois, J. F.; Hubert, P.; Rozet, E. Implementation of a design space approach for enantiomeric separations in polar organic solvent chromatography. J. Pharm. Biomed. Anal. 2013, 74, 273–283.
   PubMed Web of Science ®Google Scholar
• Schweitzer, M.; Pohl, M.; Hanna-Brown, M.; Nethercote, P.; Borman, P.; Hansen, G.; Smith, K.; Larew, J. Implications and Opportunities of Applying QbD Principles to Analytical Measurements. Published by Drug Chemicals & Associated Technologies Association (DCAT), NJ, USA, 2010, pp. 52–53.
   Google Scholar
• Vogt, F. G.; Kord, A. S. Development of quality-by-design analytical methods. J. Pharm. Sci. 2011, 100, 797–812.
   PubMed Web of Science ®Google Scholar
• Bhatia, A.; Kumar, R.; Katare, O. P. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J. Pharm. Pharm. Sci., 2004, 7, 252–259.
   PubMed Web of Science ®Google Scholar
• Yuan, H., Wang, L., Du, Y. Z., You, J., Hu, Q. F., Zeng, S. An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Colloids Surf. B. Biointerfaces 2011, 87, 180–186.
   PubMed Web of Science ®Google Scholar
• Jain, A. K.; Jain, A.; Garg, N. K.; Agarwal, A.; Jain, A.; Jain, S. A.; Tyagi, R. K.; Jain, R. K.; Agrawal, H.; Agrawal, G. P. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf. B. Biointerfaces 2014, 121, 222–229.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Chan, J. M.; Gu, F. X.; Rhee, J. W.; Wang, A. Z.; Radovic-Moreno, A. F.; Alexis, F.; Langer, R.; Farokhzad, O. C. Self-assembled lipid–polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008, 2, 1696–1702.
   PubMed Web of Science ®Google Scholar
• Singh, B.; Kumar, R.; Ahuja, N. Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit. Rev. Ther. Drug Carrier Syst. 2005, 22, 27–105.
   PubMed Web of Science ®Google Scholar